We are live on ! Find out more
STLN

Starling Oncology Institute, Inc. Common Stock
STLN

21 hedge funds and large institutions have $49.3M invested in Starling Oncology Institute, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

21.97% more ownership

Funds ownership: 0% → 21.97% (+22%)

Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
$1.14M
Puts
–
Net Calls
+$1.14M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$13.7M
2
Deutsche Bank
Deutsche Bank
Germany
+$7.93M
3
HI
HBK Investments
Texas
+$4.97M
4
FTCM
Fir Tree Capital Management
New York
+$2.49M
5
MCM
Moore Capital Management
New York
+$2.49M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
1
UBS O'Connor
Illinois
$13.8M +$13.7M +1,377,500 New
Deutsche Bank
2
Deutsche Bank
Germany
$8.01M +$7.93M +797,028 New
HI
3
HBK Investments
Texas
$5.03M +$4.97M +500,000 New
MCM
4
Moore Capital Management
New York
$2.54M +$2.49M +250,000 New
FTCM
5
Fir Tree Capital Management
New York
$2.51M +$2.49M +250,000 New
RCM
6
Radcliffe Capital Management
Pennsylvania
$2.51M +$2.49M +250,000 New
Hudson Bay Capital Management
7
Hudson Bay Capital Management
Connecticut
$2.5M +$2.45M +246,376 New
OCAM
8
Owl Creek Asset Management
New York
$2.01M +$1.99M +199,996 New
PMAM
9
Picton Mahoney Asset Management
Ontario, Canada
$2.01M +$1.99M +200,000 New
BCM
10
Basso Capital Management
Connecticut
$1.46M +$1.45M +145,485 New
Millennium Management
11
Millennium Management
New York
$1.1M +$1.09M +109,800 New
DAM
12
Deltec Asset Management
New York
$1M +$995K +100,000 New
LA
13
Linden Advisors
New York
$1M +$995K +100,000 New
TCM
14
Tenor Capital Management
New York
$1M +$995K +100,000 New
WAM
15
Wolverine Asset Management
Illinois
$771K +$763K +76,725 New
MIM
16
Monashee Investment Management
Massachusetts
$754K +$746K +74,996 New
CC
17
Centiva Capital
New York
$503K +$497K +50,000 New
DCM
18
Dupont Capital Management
Delaware
$503K +$497K +50,000 New
AA
19
AQR Arbitrage
Connecticut
$250K +$249K +25,000 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$3K +$2.98K +300 New
JG
21
Jefferies Group
New York
$1.51K +$1.5M +150,593 New

STLN Hedge Fund Activity: Q2 2020 in Review

21 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology Institute, Inc. Common Stock (STLN) for Q2 2020, worth a combined $49.3M.

Buyers outnumbered sellers: 21 funds opened new STLN positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $13.7M.

  • 21 institutional investors held Starling Oncology Institute, Inc. Common Stock (STLN) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $49.3M of Starling Oncology Institute, Inc. Common Stock stock for Q2 2020.
  • 21 funds opened new Starling Oncology Institute, Inc. Common Stock positions in Q2 2020 and 0 closed out, a net change of +21 holders.
  • The largest Starling Oncology Institute, Inc. Common Stock buyer in Q2 2020 was UBS O'Connor, an estimated $13.7M added.

Based on aggregated 13F filings for Q2 2020.